Checkpoint Therapeutics Stock Price on October 29, 2024
| CKPT Stock | USD 3.75 0.28 8.07% |
Below is the normalized historical share price chart for Checkpoint Therapeutics extending back to December 19, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Checkpoint Therapeutics stands at 3.75, as last reported on the 25th of November, with the highest price reaching 3.81 and the lowest price hitting 3.46 during the day.
If you're considering investing in Checkpoint Stock, it is important to understand the factors that can impact its price. Checkpoint Therapeutics appears to be slightly risky, given 3 months investment horizon. Checkpoint Therapeutics secures Sharpe Ratio (or Efficiency) of 0.22, which signifies that the company had a 0.22% return per unit of standard deviation over the last 3 months. By analyzing Checkpoint Therapeutics' technical indicators, you can evaluate if the expected return of 0.88% is justified by implied risk. Please makes use of Checkpoint Therapeutics' mean deviation of 3.12, and Risk Adjusted Performance of 0.1669 to double-check if our risk estimates are consistent with your expectations.
At this time, Checkpoint Therapeutics' Common Stock Total Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 19.7 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 5.1 M in 2024. . At this time, Checkpoint Therapeutics' Price To Sales Ratio is comparatively stable compared to the past year. Price Sales Ratio is likely to gain to 437.54 in 2024, whereas Price Earnings Ratio is likely to drop (0.87) in 2024. Checkpoint Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of June 2017 | 200 Day MA 2.2501 | 50 Day MA 2.943 | Beta 1.235 |
Checkpoint |
Sharpe Ratio = 0.2196
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CKPT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.01 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.88 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Checkpoint Therapeutics is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Checkpoint Therapeutics by adding it to a well-diversified portfolio.
Price Book 8.5555 | Enterprise Value Ebitda (0.54) | Price Sales 2.3 K | Shares Float 34.8 M | Wall Street Target Price 17 |
Related Headline
Seres Therapeutics Headline on 29th of October 2024
Seres Therapeutics executive sells stock for 2,749 by investing.com
Seres Therapeutics executive sells stock for 2,749
Checkpoint Therapeutics Valuation on October 29, 2024
It is possible to determine the worth of Checkpoint Therapeutics on a given historical date. On October 29, 2024 Checkpoint was worth 3.71 at the beginning of the trading date compared to the closed value of 3.84. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Checkpoint Therapeutics stock. Still, in general, we apply an absolute valuation method to find Checkpoint Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Checkpoint Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Checkpoint Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.75 | 3.80 | 3.49 | 3.68 | 2,039,765 | |
10/29/2024 | 3.71 | 3.95 | 3.52 | 3.84 | 2,111,565 |
| 3.83 | 3.97 | 3.60 | 3.62 | 2,395,828 |
| Backtest Checkpoint Therapeutics | | | Checkpoint Therapeutics History | | | Checkpoint Therapeutics Valuation | Previous | Next |
Checkpoint Therapeutics Trading Date Momentum on October 29, 2024
| On October 30 2024 Checkpoint Therapeutics was traded for 3.62 at the closing time. The top price for the day was 3.97 and the lowest listed price was 3.60 . The trading volume for the day was 2.4 M. The trading history from October 30, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.73% . The overall trading delta against the current closing price is 8.85% . |
Checkpoint Therapeutics Fundamentals Correlations and Trends
By evaluating Checkpoint Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Checkpoint Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Checkpoint financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Checkpoint Therapeutics Stock history
Checkpoint Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Checkpoint is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Checkpoint Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Checkpoint Therapeutics stock prices may prove useful in developing a viable investing in Checkpoint Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 18.7 M | 19.7 M | |
| Net Loss | -51 M | -48.5 M |
Checkpoint Therapeutics Stock Technical Analysis
Checkpoint Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Checkpoint Therapeutics Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Checkpoint Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Checkpoint Therapeutics November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Checkpoint Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Checkpoint Therapeutics shares will generate the highest return on investment. By undertsting and applying Checkpoint Therapeutics stock market strength indicators, traders can identify Checkpoint Therapeutics entry and exit signals to maximize returns
Checkpoint Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Checkpoint Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Checkpoint Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Checkpoint to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1669 | |||
| Jensen Alpha | 0.79 | |||
| Total Risk Alpha | 0.1864 | |||
| Sortino Ratio | 0.1933 | |||
| Treynor Ratio | 4.89 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Checkpoint Stock Analysis
When running Checkpoint Therapeutics' price analysis, check to measure Checkpoint Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Checkpoint Therapeutics is operating at the current time. Most of Checkpoint Therapeutics' value examination focuses on studying past and present price action to predict the probability of Checkpoint Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Checkpoint Therapeutics' price. Additionally, you may evaluate how the addition of Checkpoint Therapeutics to your portfolios can decrease your overall portfolio volatility.